Mads Hald Andersen

Also affiliated with Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, Rigshospitalet, IT University of Copenhagen

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas”.

MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas

Cancers(2020)10.3390/cancers12051229

N/A

0DataRank · unranked

45 citations

Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum, Lise M. Lindahl, Terkild B. Buus, Mads Hald Andersen +12 more

IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0457

N/A

0DataRank · unranked

26 citations

Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Zainab Ramlaoui +8 more

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

Journal of Hematology & Oncology(2025)10.1186/s13045-024-01634-6

N/A

0DataRank · unranked

131 citations

Hannah Lau, Lukas M. Carter, E. Hui Clarissa Lee, Hiu Yan Lam, Elena Okina +34 more

Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1856

N/A

0DataRank · unranked

9 citations

Chella Krishna Vadivel, Maria Gluud, Martin R.J. Namini, Ziao Zeng, Signe Hedebo +22 more